Print Page

Products found to contain undeclared medicines

Singapore: HSA Alerts Public to Illegal Product 'AMACE for him' Found to Contain Undeclared Chemical Ingredient
The Health Sciences Authority (HSA) is alerting members of the public not to consume an illegal product ‘AMACE for him’ as it was tested to contain a potent undeclared chemical ingredient, N-cyclopentyl nortadalfil. N-cyclopentyl nortadalfil is an analogue (a chemically-related compound) of tadalafil, a prescription medicine which is used in the treatment of male impotence, and may cause serious adverse effects. These include headaches, dizziness, high blood pressure, chest pain and muscle aches. In addition, tadalafil and its analogues should not be used by patients with certain medical conditions, including heart problems, or patients who are taking heart medications such as nitrates as fatalities have been reported.

Although HSA has not yet received any adverse reaction reports associated with ‘AMACE for him”, this does not mean that the product does not cause any harm. Persons taking the product may not link the adverse effects they experienced with the product or share with their doctors that they are taking such a product. Consumers should be aware that illegal health products are generally produced under poor manufacturing conditions with no quality control, and the contents of the product can vary from batch to batch, which can pose serious health hazards.

‘AMACE for him’ was sold locally by Acupoint Pte Ltd located at Balestier Plaza. The product claimed to be a health supplement containing only natural ingredients, including lingzhi, ginseng, cordyceps and wolfberry. ‘AMACE for him’ was marketed to ‘enhance energy level and blood circulation’ as well as ‘strengthen immune system for general well-being’ and claims to ‘arouse the sexual nerves’. The company has since stopped all sales of the product as instructed by HSA.

Please refer to the following website in HSA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Thursday, October 09, 2014
Issued at HKT 15:00